Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Taxes (2016 - 2026)

Iradimed has reported Current Taxes over the past 11 years, most recently at $3.9 million for Q1 2026.

  • Quarterly Current Taxes rose 568.83% to $3.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2026, up 568.83% year-over-year, with the annual reading at $1.8 million for FY2025, N/A changed from the prior year.
  • Current Taxes was $3.9 million for Q1 2026 at Iradimed, up from $1.8 million in the prior quarter.
  • Over five years, Current Taxes peaked at $3.9 million in Q1 2026 and troughed at $250041.0 in Q4 2023.
  • The 4-year median for Current Taxes is $928287.0 (2024), against an average of $1.5 million.
  • Year-over-year, Current Taxes plummeted 37.15% in 2025 and then surged 568.83% in 2026.
  • A 4-year view of Current Taxes shows it stood at $250041.0 in 2023, then surged by 271.25% to $928287.0 in 2024, then surged by 95.41% to $1.8 million in 2025, then soared by 115.1% to $3.9 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Current Taxes are $3.9 million (Q1 2026), $1.8 million (Q4 2025), and $2.8 million (Q3 2025).